{
    "organizations": [],
    "uuid": "bc6262b48a2744c9f1b82fa589e54a36d047d92d",
    "author": "",
    "url": "https://www.reuters.com/article/brief-astellas-pharma-signs-exclusive-li/brief-astellas-pharma-signs-exclusive-licensing-agreement-with-aquinox-pharmaceuticals-idUSL3N1SH17A",
    "ord_in_thread": 0,
    "title": "BRIEF- Astellas Pharma signs exclusive licensing agreement with Aquinox Pharmaceuticals",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 10(Reuters) - Astellas Pharma Inc\n* Says it signed an exclusive license agreement with Aquinox Pharmaceuticals, Inc for Japan and certain other countries in the Asia-Pacific region for Astellas to develop and commercialize rosiptor, Aquinoxâ€™s lead drug candidate, a first-in-class, once-daily oral treatment currently in Phase 3 clinical development for interstitial cystitis/bladder pain syndrome (IC/BPS) in North America and Europe\n* Under the agreement, Astellas will have the exclusive right to research, develop, and commercialize rosiptor for all human diseases and conditions in Japan and additional countries in the Asia-Pacific region\nSource text in Japanese: goo.gl/rBWrLH\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-05-10T04:20:00.000+03:00",
    "crawled": "2018-05-10T04:39:24.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "astellas",
        "pharma",
        "inc",
        "say",
        "signed",
        "exclusive",
        "license",
        "agreement",
        "aquinox",
        "pharmaceutical",
        "inc",
        "japan",
        "certain",
        "country",
        "region",
        "astellas",
        "develop",
        "commercialize",
        "rosiptor",
        "aquinox",
        "lead",
        "drug",
        "candidate",
        "oral",
        "treatment",
        "currently",
        "phase",
        "clinical",
        "development",
        "interstitial",
        "pain",
        "syndrome",
        "north",
        "america",
        "europe",
        "agreement",
        "astellas",
        "exclusive",
        "right",
        "research",
        "develop",
        "commercialize",
        "rosiptor",
        "human",
        "disease",
        "condition",
        "japan",
        "additional",
        "country",
        "region",
        "source",
        "text",
        "japanese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}